Difficulty: Medium
Average Score: 77%
Practice
A 34-year-old man with allergic rhinitis presents to his primary care physician for treatment. He is prescribed diphenhydramine and develops dry eyes and mouth within 2 days. His symptoms of rhinitis are approximately 75% better. He calls his physician asking what he should do. The most appropriate management for this patient is which of the following?
Correct answer
A
Rationale
The correct answer is to continue the medication at the current dose (Option A). Diphenhydramine is an antihistamine commonly known to cause anticholinergic side effects like dry eyes and mouth. However, these side effects are usually mild and transient. In this case, since the patient's allergic rhinitis symptoms have improved significantly, it is appropriate to continue the medication as it is effectively managing the primary condition.
Discontinuing diphenhydramine (Option B) may lead to a resurgence of allergic rhinitis symptoms, which have shown improvement with the current treatment. Starting therapy with chlorpheniramine in addition to diphenhydramine (Option C) may increase the risk of additive side effects without clear benefit in this scenario. Referring the patient for surgical consultation for rhinoplasty (Option D) is not indicated at this point as the primary issue is allergic rhinitis, not a structural problem.
From an educational perspective, this scenario highlights the importance of understanding common side effects of medications and appropriate management strategies. It also emphasizes the need to assess the overall benefit-risk ratio of a treatment plan in the context of the patient's presenting symptoms and response to therapy.
Discontinuing diphenhydramine (Option B) may lead to a resurgence of allergic rhinitis symptoms, which have shown improvement with the current treatment. Starting therapy with chlorpheniramine in addition to diphenhydramine (Option C) may increase the risk of additive side effects without clear benefit in this scenario. Referring the patient for surgical consultation for rhinoplasty (Option D) is not indicated at this point as the primary issue is allergic rhinitis, not a structural problem.
From an educational perspective, this scenario highlights the importance of understanding common side effects of medications and appropriate management strategies. It also emphasizes the need to assess the overall benefit-risk ratio of a treatment plan in the context of the patient's presenting symptoms and response to therapy.